Brain Trust Accelerator Fund - aVenture Asset Manager Research
Location
Burlingame, CA, US
Founded
2006
Brain Trust Accelerator Fund is a venture capital firm specializing in early-stage investments for brain-related disease diagnosis and treatment. The fund focuses on impact investing in the neuroscience sector, typically participating in Series A and Series B funding rounds.
Notable portfolio companies include Chase Therapeutics, NeuroTherapia, and Satoris. Brain Trust Accelerator Fund has demonstrated a commitment to advancing innovative solutions in the field of brain health, with investments ranging from $5 million to $20 million in their portfolio companies.
Brain Trust Accelerator Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count2
Top Investment Stages
Series B2 (66.7%)
Series A1 (33.3%)
Stage Mix
Series B 67%Series A 33%
Concentration shown as share of disclosed investments by stage.